A rare cause of massive ascites: Familial Mediterranean fever

Aslan, Mehmet; Demir, Güner; Esen, Ramazan; Dülger, Ahmet Cumhur; Beğenik, Hüseyin; Çelik, Yılmaz; Küçükoğlu, Mehmet Emin; Bahar, Kadir

doi:10.4318/tjg.2012.0374

Cited by 3 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The striking feature of our case presentation is the fact that the young male patient did not present with fever, similar to findings observed by Hotta and Mattiassich et al [7,8]. Cekin and Aslan et al [9,10] had identical complaints to our patient comprising abdominal ascites. Aslan et al [10], however, did not note abdominal pain, which was identified by Tatar and Lee et al [11,12], but without distention secondary to ascites.…”

Section: Discussionsupporting

confidence: 90%

“…Cekin and Aslan et al [9,10] had identical complaints to our patient comprising abdominal ascites. Aslan et al [10], however, did not note abdominal pain, which was identified by Tatar and Lee et al [11,12], but without distention secondary to ascites. Incidentally, it was discovered soon after the initial workup that our patient also had added heart sounds, who was later diagnosed to have pericardial effusion.…”

Section: Discussionsupporting

confidence: 80%

See 1 more Smart Citation

Deep Dive Into Familial Mediterranean Fever in a Child Without Fever

Jaiswal¹,

Sarfraz²,

Paul³

et al. 2021

Cureus

View full text Add to dashboard Cite

This case report entails the details of a 12-year-old Egyptian boy who had recurrent episodes of shortness of breath, ascites, and pericardial effusions starting at the age of 10, returning with worsening symptoms in April of 2020. The lab findings indicated a critically elevated C-reactive protein (CRP) of 107.2 mg/L; a clinically notable inflammation process was festering. This case was all the more interesting as this boy did not present with a fever, making the diagnosis a difficult one. Nonetheless, genetic Mediterranean fever (MEFv) and polymerase chain reaction (PCR) testing confirmed the diagnosis of familial MEFv. Steroids and colchicine-salicylate decreased the frequency of the attacks and are now on half a dose of colchicine to keep his symptoms at bay. What we see here is the risk-to-benefit ratio of the therapeutic use of colchicine in children outweighs potential side effects such as nausea, vomiting, abdominal pain, diarrhea, kidney or liver failure. However, further research is needed to access better long-term treatment plans. Another key takeaway point that can be highlighted in this case is that the patient does not need to be febrile to diagnose FMF.

show abstract